Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies

Author： Sun Nan   Taguchi Ayumu   Hanash Samir  

Publisher： MDPI

E-ISSN： 2077-0383|5|12|109-109

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.5, Iss.12, 2016-11, pp. : 109-109

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target

By Yee Nelson S.  

Pharmaceuticals, Vol. 10, Iss. 2, 2017-04 ,pp. : 39-39

MDPI

Access to resources Recommend Favorite

MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer

By Chou Chen-Kai   Liu Rue-Tsuan   Kang Hong-Yo  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 636-636

MDPI

Access to resources Recommend Favorite

Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-β (TGF-β) Signaling in Cancer

By Khin Sann Sanda   Kitazawa Riko   Kondo Takeshi   Idei Yuka   Fujimoto Masayo   Haraguchi Ryuma   Mori Kiyoshi   Kitazawa Sohei  

Cancers, Vol. 3, Iss. 1, 2011-03 ,pp. : 982-993

MDPI

Access to resources Recommend Favorite

Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma

By Nakaoka Toshiaki   Saito Yoshimasa   Saito Hidetsugu  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-05 ,pp. : 1111-1111

MDPI

Access to resources Recommend Favorite

Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer

By Witte David   Zeeh Franziska   Gädeken Thomas   Gieseler Frank   Rauch Bernhard H.   Settmacher Utz   Kaufmann Roland   Lehnert Hendrik   Ungefroren Hendrik  

Journal of Clinical Medicine, Vol. 5, Iss. 12, 2016-11 ,pp. : 111-111

MDPI

Access to resources Recommend Favorite